Co-foundeur and scientific advisor of Inatherys.
Ivan graduated from the University of Sao Paulo, Brazil, in 1996. He did a post-doctoral internship at Curie Institute and then at Necker hospital from 2003 to 2006. In 2007, he was appointed researcher at INSERM in U699 unit at Bichat hospital, which was managed by Dr. Renato Monteiro. Dr. Moura participated in 34 international scientific articles (which 21 were published in highly renowned journals) and obtained several funding (FRM, INCA, ANR, ARC).
He also took part in both patents. Dr. Moura characterized the anti-tumor properties of the monoclonal antibody anti-TfR1 (A24/INA01). As an INSERM researcher, he brings to Inatherys his expertise in establishing proof about the in vivo concept of antibodies use and his extensive knowledge of toxicological studies as well as bio-production of humanized antibodies.